EVOLOCUMAB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 17 adverse event reports in the FDA FAERS database where EVOLOCUMAB was used for Psoriasis.
Most Reported Side Effects for EVOLOCUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Device difficult to use | 31,807 | 21.3% | 11 | 538 |
| Drug dose omission by device | 23,957 | 16.0% | 7 | 327 |
| Wrong technique in product usage process | 21,664 | 14.5% | 4 | 285 |
| Accidental exposure to product | 16,160 | 10.8% | 3 | 154 |
| Injection site pain | 9,988 | 6.7% | 3 | 154 |
| Product storage error | 6,606 | 4.4% | 2 | 88 |
| Back pain | 5,254 | 3.5% | 14 | 201 |
| Myalgia | 5,061 | 3.4% | 15 | 177 |
| Drug dose omission | 4,914 | 3.3% | 1 | 87 |
| Injection site bruising | 4,409 | 3.0% | 1 | 83 |
| Device use error | 4,002 | 2.7% | 0 | 76 |
| Injection site haemorrhage | 3,720 | 2.5% | 1 | 50 |
| Arthralgia | 3,692 | 2.5% | 10 | 175 |
| Off label use | 3,558 | 2.4% | 23 | 153 |
| Fatigue | 3,506 | 2.3% | 7 | 165 |
Other Indications for EVOLOCUMAB
Product used for unknown indication (60,696)
Blood cholesterol increased (29,401)
Hypercholesterolaemia (23,505)
Blood cholesterol abnormal (13,116)
Hyperlipidaemia (10,208)
Type iia hyperlipidaemia (5,556)
Low density lipoprotein increased (2,740)
Arteriosclerosis (2,094)
Type v hyperlipidaemia (1,816)
Coronary artery disease (1,266)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)